{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:12:35Z","timestamp":1788995555314,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(No. 82072853"],"award-info":[{"award-number":["(No. 82072853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Uterine tumors resembling ovarian sex cord tumor (UTROSCT) is a rare neoplasm of unknown etiology and has undetermined malignant potential. The emergence of recurrent UTROSCT case reports has led to its initial identification as a tumor of low malignancy potential. Owing to its low incidence, we currently lack any in-depth studies regarding the subset of UTROSCTs that may be aggressive in nature. Here, we sought to identify unique characteristics in aggressive UTROSCT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>19 cases of UTROSCT were collected. Their histologic and tumor immune microenvironment were evaluated by three gynecologic pathologists. The gene alteration was also detected by RNA sequencing. For later analyses regarding differences between benign and malignant tumors, we supplemented our 19 included cases with additional reports from the literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Interestingly, we found PD-L1 expression in stromal tumor-infiltrating immune cells (stromal PD-L1) was markedly higher in aggressive UTROSCT. Patients with high stromal PD-L1 (\u2265\u200922.5 cells\/mm<jats:sup>2<\/jats:sup>) had worse prognosis. When our cases were added with previous cases identified in the literature, we discovered that aggressive UTROSCT was more likely to have significant mitotic activity and NCOA2 gene alterations than benign UTROSCT. Consistence with those results, patients with significant mitotic activity and gene alteration of NCOA2 had worse prognoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Collectively, high expression of stromal PD-L1, significant mitotic activity, and gene alteration of NCOA2 may be useful markers to predict aggressive UTROSCT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01183-5","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:06:44Z","timestamp":1684858004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["PD-L1 expression, morphology, and molecular characteristic of a subset of aggressive uterine tumor resembling ovarian sex cord tumor and a literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Si-Ping","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Zhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Peng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"1183_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PAS.0000000000001153","volume":"43","author":"BC Dickson","year":"2019","unstructured":"Dickson BC, Childs TJ, Colgan TJ, Sung YS, Swanson D, Zhang L, Antonescu CR. Uterine tumor resembling ovarian sex cord tumor: a distinct entity characterized by recurrent NCOA2\/3 gene fusions. Am J Surg Pathol. 2019;43:178\u201386.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PAS.0000000000001348","volume":"44","author":"EA Goebel","year":"2020","unstructured":"Goebel EA, Hernandez Bonilla S, Dong F, Dickson BC, Hoang LN, Hardisson D, Lacambra MD, Lu FI, Fletcher CDM, Crum CP, et al. Uterine tumor resembling ovarian sex cord tumor (UTROSCT): a morphologic and molecular study of 26 cases confirms recurrent NCOA1-3 rearrangement. Am J Surg Pathol. 2020;44:30\u201342.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR3","first-page":"53","volume":"21","author":"RP Morehead","year":"1945","unstructured":"Morehead RP, Bowman MC. Heterologous mesodermal tumors of the Uterus: report of a Neoplasm resembling a Granulosa Cell Tumor. Am J Pathol. 1945;21:53\u201361.","journal-title":"Am J Pathol"},{"key":"1183_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ajcp\/66.3.512","volume":"66","author":"PB Clement","year":"1976","unstructured":"Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol. 1976;66:512\u201325.","journal-title":"Am J Clin Pathol"},{"key":"1183_CR5","unstructured":"Staats PN, Irving JA, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour. WHO Classification of Tumours Editorial Board.Female Genital Tumours, 5th ed.(International Agency for Research on Cancer, World Health Organization, 2020)."},{"key":"1183_CR6","doi-asserted-by":"publisher","first-page":"100636","DOI":"10.1016\/j.gore.2020.100636","volume":"34","author":"WR Grither","year":"2020","unstructured":"Grither WR, Dickson BC, Fuh KC, Hagemann IS. Detection of a somatic GREB1-NCOA1 gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT). Gynecol Oncol Rep. 2020;34:100636.","journal-title":"Gynecol Oncol Rep"},{"key":"1183_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/PAS.0000000000000367","volume":"39","author":"S Chiang","year":"2015","unstructured":"Chiang S, Staats PN, Senz J, Kommoss F, De Nictolis M, Huntsman DG, Gilks CB, Oliva E. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors. Am J Surg Pathol. 2015;39:618\u201323.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/PAS.0b013e3181a7b9cf","volume":"33","author":"PN Staats","year":"2009","unstructured":"Staats PN, Garcia JJ, Dias-Santagata DC, Kuhlmann G, Stubbs H, McCluggage WG, De Nictolis M, Kommoss F, Soslow RA, Iafrate AJ, Oliva E. Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol. 2009;33:1206\u201312.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/PGP.0000000000000240","volume":"35","author":"S Croce","year":"2016","unstructured":"Croce S, de Kock L, Boshari T, Hostein I, Velasco V, Foulkes WD, McCluggage WG. Uterine tumor resembling ovarian sex cord tumor (UTROSCT) commonly exhibits positivity with sex cord markers FOXL2 and SF-1 but lacks FOXL2 and DICER1 mutations. Int J Gynecol Pathol. 2016;35:301\u20138.","journal-title":"Int J Gynecol Pathol"},{"key":"1183_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2014.07.050","volume":"181","author":"EA Blake","year":"2014","unstructured":"Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M, Sawada K, Matsuo K. Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014;181:163\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1183_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/his.13296","volume":"71","author":"M Moore","year":"2017","unstructured":"Moore M, McCluggage WG. Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow-up. Histopathology. 2017;71:751\u20139.","journal-title":"Histopathology"},{"key":"1183_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/PAS.0000000000001254","volume":"43","author":"ED Shanes","year":"2019","unstructured":"Shanes ED, Friedman LA, Mills AM. PD-L1 expression and tumor-infiltrating lymphocytes in uterine smooth muscle tumors: implications for Immunotherapy. Am J Surg Pathol. 2019;43:792\u2013801.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/PAS.0000000000001786","volume":"45","author":"KA Devereaux","year":"2021","unstructured":"Devereaux KA, Kertowidjojo E, Natale K, Ewalt MD, Soslow RA, Hodgson A. GTF2A1-NCOA2-Associated Uterine Tumor resembling ovarian sex cord tumor (UTROSCT) shows focal Rhabdoid morphology and aggressive behavior. Am J Surg Pathol. 2021;45:1725\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ijgo.13360","volume":"152","author":"Z Chen","year":"2021","unstructured":"Chen Z, Lan J, Chen Q, Lin D, Hong Y. A novel case of uterine tumor resembling ovarian sex-cord tumor (UTROSCT) recurrent with GREB1-NCOA2 fusion. Int J Gynaecol Obstet. 2021;152:266\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"1183_CR15","doi-asserted-by":"crossref","unstructured":"Cascone T, Fradette J, Pradhan M, Gibbons DL. Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer. Cold Spring Harb Perspect Med 2022, 12.","DOI":"10.1101\/cshperspect.a037895"},{"key":"1183_CR16","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2217\/fon-2021-1087","volume":"18","author":"M Zhao","year":"2022","unstructured":"Zhao M, Duan X, Mi L, Shi J, Li N, Yin X, Han X, Wang J, Han G, Hou J, Yin F. Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index. Future Oncol. 2022;18:2269\u201388.","journal-title":"Future Oncol"},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/07853890.2022.2067894","volume":"54","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Q, Yang WK, Wang YS, Zhou Q, Lin J, Wei XX, Liang T, Liu T, Fan WT, et al. Development of an immune-related prognostic biomarker for triple-negative breast cancer. Ann Med. 2022;54:1212\u201320.","journal-title":"Ann Med"},{"key":"1183_CR18","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R. Tumor Mutational Burden as an independent predictor of response to Immunotherapy in Diverse Cancers. Mol Cancer Ther. 2017;16:2598\u2013608.","journal-title":"Mol Cancer Ther"},{"key":"1183_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48\u201361.","journal-title":"Cell"},{"key":"1183_CR20","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"1183_CR21","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","volume":"20","author":"JM Taube","year":"2014","unstructured":"Taube JM, Klein A, Brahmer JR, Xu H, Pan X, Kim JH, Chen L, Pardoll DM, Topalian SL, Anders RA. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res. 2014;20:5064\u201374.","journal-title":"Clin Cancer Res"},{"key":"1183_CR22","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455\u201365.","journal-title":"N Engl J Med"},{"key":"1183_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13048-019-0526-0","volume":"12","author":"KH Kim","year":"2019","unstructured":"Kim KH, Choi KU, Kim A, Lee SJ, Lee JH, Suh DS, Kwon BS, Hwang C. PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma. J Ovarian Res. 2019;12:56.","journal-title":"J Ovarian Res"},{"key":"1183_CR24","doi-asserted-by":"crossref","unstructured":"Ye S, Wu J, Yao L, He J. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours. J Clin Pathol 2021.","DOI":"10.1136\/jclinpath-2021-207441"},{"key":"1183_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/gcc.22909","volume":"60","author":"YC Kao","year":"2021","unstructured":"Kao YC, Lee JC. An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1-rearranged uterine sarcoma with variable sex-cord differentiation. Genes Chromosomes Cancer. 2021;60:180\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"1183_CR26","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/PAS.0000000000001543","volume":"44","author":"JA Bennett","year":"2020","unstructured":"Bennett JA, Lastra RR, Barroeta JE, Parilla M, Galbo F, Wanjari P, Young RH, Krausz T, Oliva E. Uterine tumor resembling ovarian sex cord stromal tumor (UTROSCT): a Series of 3 cases with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions. Am J Surg Pathol. 2020;44:1563\u201372.","journal-title":"Am J Surg Pathol"},{"key":"1183_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13000-020-01025-8","volume":"15","author":"B Chang","year":"2020","unstructured":"Chang B, Bai Q, Liang L, Ge H, Yao Q. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review. Diagn Pathol. 2020;15:110.","journal-title":"Diagn Pathol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01183-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:10:50Z","timestamp":1684858250000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01183-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"16 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"UTROSCT, Uterine tumors resembling ovarian sex cord tumor; ESTSCLEs, endometrial stromal tumors with sex cord-like elements; WHO, World Health Organization; NGS, next-generation sequencing; GREB1, growth regulating estrogen receptor binding 1; NCOA, nuclear receptor coactivator;","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Abbreviations"}},{"value":"Our study was approved by the Institutional Ethical Boards of Sun Yat-sen University Cancer Center. Written informed consent was obtained for each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"102"}}